Abstract
Sleep disturbances are very common in cancer patients. They are part of a symptom cluster with fatigue and pain that greatly affect quality of life in these patients. Lung cancer patients are found to have the highest prevalence of sleep disturbances. However, these disturbances have not been as well-studied in the lung cancer patients. Though insomnia is the most common disorder seen in these patients, other sleep disorders like excessive daytime sleepiness, limb movement disorders and circadian rhythm disorders have also been described. Treatment of these disorders may affect the prognosis of patients with lung cancer. More studies should be done to elucidate the details of sleep disturbances in lung cancer patients.
Keywords: Lung cancer and sleep disturbances, insomnia and lung cancer, restless legs syndrome and cancer
Current Respiratory Medicine Reviews
Title: Sleep Disturbances in Lung Cancer Patients
Volume: 5 Issue: 4
Author(s): Kanta Velamuri
Affiliation:
Keywords: Lung cancer and sleep disturbances, insomnia and lung cancer, restless legs syndrome and cancer
Abstract: Sleep disturbances are very common in cancer patients. They are part of a symptom cluster with fatigue and pain that greatly affect quality of life in these patients. Lung cancer patients are found to have the highest prevalence of sleep disturbances. However, these disturbances have not been as well-studied in the lung cancer patients. Though insomnia is the most common disorder seen in these patients, other sleep disorders like excessive daytime sleepiness, limb movement disorders and circadian rhythm disorders have also been described. Treatment of these disorders may affect the prognosis of patients with lung cancer. More studies should be done to elucidate the details of sleep disturbances in lung cancer patients.
Export Options
About this article
Cite this article as:
Velamuri Kanta, Sleep Disturbances in Lung Cancer Patients, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112500
DOI https://dx.doi.org/10.2174/157339809790112500 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Sleeping Beauty Transposon Vector System for Treatment of Rare Genetic Diseases: An Unrealized Hope?
Current Gene Therapy Mitochondrial Mechanisms of Metabolic Reprogramming in Proliferating Cells
Current Medicinal Chemistry Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research
Recent Patents on Anti-Cancer Drug Discovery Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
Current Pharmaceutical Design Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism
Current Pharmaceutical Design Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
CNS & Neurological Disorders - Drug Targets Recent Progress on Development of TiO2 Thin Film Photocatalysts for Pollutant Removal
Recent Patents on Materials Science Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Current Respiratory Medicine Reviews Benefits of Structural Genomics for Drug Discovery Research
Infectious Disorders - Drug Targets Culturally Informed Care of the Turkish-American Child, Adolescent, and Family
Adolescent Psychiatry Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Recent Advances in Physical Delivery Enhancement of Topical Drugs
Current Pharmaceutical Design Early Features in Frontotemporal Dementia
Current Alzheimer Research Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Current Drug Targets Lysosomal Storage Diseases and the Blood-Brain Barrier
Current Pharmaceutical Design HSP60 as a Drug Target
Current Pharmaceutical Design Dendritic Chemistry Applied to the Construction of Tailored Functional Nanomaterials: Synthesis and Characterization of Gold Nanoparticle-Cored Dendrimers (NCDs)
Current Organic Chemistry